Diagnosing a Heart Attack at 10,000 Meters

CardioSecurA passenger suddenly has chest pain on board. The crew asks for a doctor; when present, this is not always a cardiologist. The pilot has to decide if a flight diversion is required or not. The dilemma: Despite having a doctor on board, crucial ECG information is missing. As more and more older people fly and the trend towards long-distance travel increases, medical emergencies on board become more common. Particularly critical are cardiovascular complaints, as a quick and targeted treatment is crucial for the survival of the passenger. At Lufthansa, the mobile ECG system CardioSecur has been used since January 2018 and enables an unprecedented infarct diagnosis in the air.

As the world's first airline, Lufthansa equipped all A380 aircraft in its fleet with the mobile ECG CardioSecur this year. The handy, 50g lightweight system complements the previous on board medical care in an initial oneyear pilot phase and forms an important interface between the crew in the aircraft and medical advice on the ground.

The intuitive system allows the cabin crew, without any cardiology expertise, to record a passenger's ECG and send it directly to International SOS, the medical hotline, for diagnosis. Dr. med. Sven-Karsten Peters, internal cardiologist for Lufthansa’s medical services is thrilled. He sees outstanding advantages in the intuitive use, the seamless integration into existing processes, and the high data quality in emergency situations on board: "Because the severity of the symptoms does not necessarily provide information about the severity of the illness, it is difficult not only for the crew, but also for the doctors on the ground, to assess whether an unscheduled landing for medical treatment is required. CardioSecur's in-depth 12-lead ECG data - straight from the plane - is a true innovation, giving physicians a much more detailed basis for decisionmaking." CardioSecur's ECG data was used on average twice per month on 14 aircrafts. The ECG interpretation from ISOS triggered the right decision with regard to necessary alternative landings every time.

For more information on the mobile ECG system, please visit:
http://www.cardiosecur.com
http://www.mobile-ecg.com

About Personal MedSystems GmbH

Personal MedSystems GmbH develops and distributes mobile ECG systems and services for private users and healthcare professionals under the name CardioSecur. CardioSecur Active is an innovative 15-lead, clinical-grade ECG for home use. In just a few seconds, it generates individualized feedback on changes in the heart health and provides a simple recommendation on whether to visit a doctor or not. The entire system consists of a 50 gram light cable with only four electrodes, the free CardioSecur Active App and the user's smartphone or tablet. CardioSecur Pro is the mobile, clinical ECG solution for physicians and healthcare professionals, as well as enterprise clients. CardioSecur Pro provides with 22 leads a 360 ° view of the heart and thereby is the only system that meets the cardiology guidelines of Europe, scrutinizing the anterior, lateral, inferior and posterior wall of the heart for infarcts.

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...